Coeptis Therapeutics Holdings (COEP) Accumulated Depreciation & Amortization (2021 - 2025)
Historic Accumulated Depreciation & Amortization for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $15217.0.
- Coeptis Therapeutics Holdings' Accumulated Depreciation & Amortization rose 447.65% to $15217.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $15217.0, marking a year-over-year increase of 447.65%. This contributed to the annual value of $14777.0 for FY2024, which is 607.28% up from last year.
- Per Coeptis Therapeutics Holdings' latest filing, its Accumulated Depreciation & Amortization stood at $15217.0 for Q3 2025, which was up 447.65% from $15070.0 recorded in Q2 2025.
- Coeptis Therapeutics Holdings' Accumulated Depreciation & Amortization's 5-year high stood at $250000.0 during Q1 2023, with a 5-year trough of $11311.0 in Q4 2021.
- Over the past 5 years, Coeptis Therapeutics Holdings' median Accumulated Depreciation & Amortization value was $14924.0 (recorded in 2025), while the average stood at $86624.0.
- Per our database at Business Quant, Coeptis Therapeutics Holdings' Accumulated Depreciation & Amortization surged by 1223.59% in 2022 and then tumbled by 9403.04% in 2025.
- Coeptis Therapeutics Holdings' Accumulated Depreciation & Amortization (Quarter) stood at $11311.0 in 2021, then grew by 12.24% to $12695.0 in 2022, then increased by 9.74% to $13931.0 in 2023, then rose by 6.07% to $14777.0 in 2024, then rose by 2.98% to $15217.0 in 2025.
- Its Accumulated Depreciation & Amortization stands at $15217.0 for Q3 2025, versus $15070.0 for Q2 2025 and $14924.0 for Q1 2025.